IL-1 RAcP

IL-1 RAcP 詳細

英語名Interleukin-1 receptor accessory protein市販薬剤の数0
治験薬の数8ターゲットの別称Interleukin-1 receptor 3,IL-1RAcP,IL-1 receptor accessory protein,IL-1R-3,C3orf13,Interleukin 1 Receptor Accessory Protein,IL1R3,Interleukin-1 Receptor Accessory Protein Beta,IL-1R3
研究&開発段階Phase 2 Clinical
英語名Interleukin-1 receptor accessory protein
ターゲットの別称Interleukin-1 receptor 3,IL-1RAcP,IL-1 receptor accessory protein,IL-1R-3,C3orf13,Interleukin 1 Receptor Accessory Protein,IL1R3,Interleukin-1 Receptor Accessory Protein Beta,IL-1R3
市販薬剤の数0
治験薬の数8
研究&開発段階Phase 2 Clinical

IL-1 RAcP 製品リスト

  • 属性

    Protein (11)Cell (1)

  • 製品ライブラリ

    オンライン (12)

  • Human (8)Mouse (1)Cynomolgus (1)Rat (1)Porcine (1)

  • タグ

    His Tag (8)Fc Tag (1)His Tag & Avi Tag (1)Fc Tag & Avi Tag (1)- (1)

  • マーカー

    Unconjugated (7)Biotin-labeled (2)FITC Labeled (1)PE Labeled (1)- (1)

IL-1 RAcPバックグランド

Interleukin-1 receptor accessory protein (IL1RAP or IL-1RAcP) is also known as Interleukin-1 receptor 3 (IL-1R-3 or IL-1R3), C3orf13, which belongs to the interleukin-1 receptor family. IL1RAP contains three Ig-like C2-type (immunoglobulin-like) domains and one TIR domain. IL1RAP is detected in liver, skin, placenta, thymus and lung. IL-1R3 / IL1RAP is coreceptor with IL1R1, associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways.

IL-1 RAcP分子の別称

IL1RAP,IL-1RAcP,C3orf13,IL1R3

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
NidanilimabCAN-04Phase 2 ClinicalLund University FoundationBiliary Tract Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Transitional Cell; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Melanoma; Myelodysplastic Syndromes; Pancreatic Neoplasms; Sarcoidosis, Pulmonary; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
詳細
CCTx-001CCTx-001Phase 2 ClinicalAdvesya SASLeukemia, Myeloid, Acute; Myelodysplastic Syndromes
詳細
SAR-445399SAR-445399Phase 2 ClinicalSanofiHidradenitis Suppurativa; Immune System Diseases; Inflammation
詳細
IBI-3011IBI-3011; IBI3011Phase 1 ClinicalArthritis, Gouty; Gout
詳細
Gene modified anti-IL1RAP Chimeric Antigen Receptor T Cells therapy(Shanghai Zhongshan Hospital)Phase 1 ClinicalShanghai Zhongshan HospitalCarcinoma, Hepatocellular
詳細
AK-135AK135; AK-135Phase 1 ClinicalPeripheral Nervous System Diseases
詳細
DXP-106DXP-106; DXP106Phase 1 ClinicalSinglomics Biopharmaceuticals Co LtdNeoplasms; Solid tumours
詳細
GSK-3903371GSK-3903371; BOS-371ClinicalGlaxosmithkline PlcNeoplasms
詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8